Editor's Note: This article contains spoilers for the Season 3 finale of 'From'. Theories about some of the biggest mysteries in From have floated around, but the Season 3 finale finally revealed some ...
Moore will play Ellis, the estranged son of Sheriff Boyd and a resident of Colony House. He is a handsome young philosopher with the soul of an artist and a deep well of unresolved trauma and rage.
Steve Kazee (Shameless), David Alpay (The Lottery) and DeVaughn Nixon (Terminator 2) have signed on for series regular roles in Syfy’s supernatural horror drama pilot The Haunted, joining previously ...
David Alpay has signed up to appear in the second season of The Borgias. The actor has landed a major recurring role in the show, Deadline reports. What to Read Next His character Calvino is an ...
EXCLUSIVE: Chloe Wepper (Good Trouble), The Lottery alum David Alpay and Brooke Smith (The Good Doctor) are set as series regulars in NBC‘s Prism pilot, from Daniel and Ben Barnz’s We’re Not Brothers ...
Plus, get the best of BroadwayWorld delivered to your inbox, and unlimited access to our editorial content across the globe. In the darkest corners of the darknet, there are terrifying places where ...
Be the first to get news, photos, videos & more.
David Alpay has been cast in a recurring role on The Vampire Diaries Season 4. The actor (The Tudors, The Borgias) will debut on the fourth episode of the fall as Professor Shane, an employee at the ...
On “The Borgias” he was known as Calvino, an Italian prince, but when David Alpay heads to Mystic Falls for the fourth season of “The Vampire Diaries,” he’ll be just a commoner named Professor Shane, ...
The Vampire Diaries has cast David Alpay in its fourth season. The Canadian actor will play the recurring role of Professor Shane, according to TVLine. The charismatic Shane is a believer in the ...
David Alpay is a Canadian actor, musician and producer, known for playing Mark Smeaton in the Showtime series The Tudors (2007) and Jade in the MGM+ science fiction horror series From (2022).